Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy

[1]  A. Bomback.  Management of Membranous Nephropathy in the PLA2R Era. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[2]  Shree G. Sharma,et al.  Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological study , 2017, Modern Pathology.

[3]  K. Mori,et al.  Analysis of PLA2R1 and HLA-DQA1 sequence variants in Japanese patients with idiopathic and secondary membranous nephropathy , 2018, Clinical and Experimental Nephrology.

[4]  Ming-hui Zhao,et al.  Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[5]  F. Spertini,et al.  Successful therapy with mycophenolic acid in a membranous glomerulonephritis due to Kimura disease
. , 2017, Clinical Nephrology.

[6]  W. Couser.  Primary Membranous Nephropathy. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[7]  D. Salant,et al.  An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[8]  K. Tokunaga,et al.  High-density Association Mapping and Interaction Analysis of PLA2R1 and HLA Regions with Idiopathic Membranous Nephropathy in Japanese , 2016, Scientific Reports.

[9]  C. Zeng,et al.  Clinicopathological features and prognosis of Kimura's disease with renal involvement in Chinese patients. , 2016, Clinical nephrology.

[10]  P. Stahl,et al.  A Mechanism for Cancer-Associated Membranous Nephropathy. , 2016, The New England journal of medicine.

[11]  Jai Radhakrishnan,et al.  Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN. , 2016, Journal of the American Society of Nephrology : JASN.

[12]  L. Beck,et al.  THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity , 2016, Modern Pathology.

[13]  G. Remuzzi,et al.  Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy , 2015, PloS one.

[14]  F. Diekmann,et al.  Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy , 2015, Transplantation.

[15]  T. Itoh,et al.  Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype , 2015, Virchows Archiv.

[16]  E. Imai,et al.  Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese , 2015, Clinical and Experimental Nephrology.

[17]  J. Klein,et al.  Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. , 2015, The New England journal of medicine.

[18]  E. Imai,et al.  Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy , 2014, Clinical and Experimental Nephrology.

[19]  J. Wetzels,et al.  Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[20]  E. Knight,et al.  Prevalence of Cancer in Membranous Nephropathy: A Systematic Review and Meta-Analysis of Observational Studies , 2014, American Journal of Nephrology.

[21]  U. Panzer,et al.  Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.

[22]  J. Higaki,et al.  Kimura's disease associated with membranous nephropathy with IgG4 and phospholipase A2 receptor-positive staining of the glomerular basement membrane. , 2014, Internal medicine.

[23]  R. Nisihara,et al.  Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients. , 2013, Human immunology.

[24]  L. McWilliam,et al.  Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. , 2013, Kidney international.

[25]  E. Messias,et al.  Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies , 2013, Modern Pathology.

[26]  U. Panzer,et al.  An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  D. Salant,et al.  Anti-phospholipase A2 receptor antibody in membranous nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[28]  T. Taguchi,et al.  [Pathology of membranous nephropathy]. , 2011, Nihon Jinzo Gakkai shi.

[29]  D. Salant,et al.  Membranous nephropathy: recent travels and new roads ahead. , 2010, Kidney international.

[30]  M. Jallouli,et al.  Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome. , 2010, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[31]  T. Nishino,et al.  Membranous nephropathy and Kimura's disease manifesting a hip mass. A case report with literature review. , 2010, Internal medicine.

[32]  David M. Beck,et al.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.

[33]  T. Fujita,et al.  Activation of the lectin complement pathway in post‐streptococcal acute glomerulonephritis , 2007, Pathology international.

[34]  B. Stengel,et al.  Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. , 2006, Kidney international.

[35]  T. Fujita,et al.  Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  A. Komatsuda,et al.  Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  A. Sherif,et al.  Kimura's disease and membranous nephropathy. , 1991, Nephron.

[38]  J. Lanfranchi,et al.  [Blood hypereosinophilia syndrome with cardiac involvement and extramembranous glomerulopathy]. , 1986, Annales de medecine interne.

[39]  Y. Miyakawa,et al.  Membranous glomerulonephritis associated with eosinophilic lymphfolliculosis of the skin (Kimura's disease): report of a case and review of the literature. , 1982, Clinical nephrology.